2020
DOI: 10.3390/ijms21030835
|View full text |Cite
|
Sign up to set email alerts
|

RPGR-Associated Dystrophies: Clinical, Genetic, and Histopathological Features

Abstract: This study describes the clinical, genetic, and histopathological features in patients with RPGR-associated retinal dystrophies. Nine male patients from eight unrelated families underwent a comprehensive ophthalmic examination. Additionally, the histopathology of the right eye from a patient with an end-stage cone-rod-dystrophy (CRD)/sector retinitis pigmentosa (RP) phenotype was examined. All RPGR mutations causing a CRD phenotype were situated in exon ORF15. The mean best-corrected visual acuity (BCVA, decim… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
29
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(30 citation statements)
references
References 46 publications
(101 reference statements)
0
29
1
Order By: Relevance
“… 58 This finding is consistent with two previous studies that reported no case of CME in patients with RPGR -RP. 9 , 35 Moreover, the lower frequency of CME observed in patients with X-linked RP (7.1%) compared to autosomal forms reported in our previous study 58 strongly suggest that the incidence of CME in RP varies according to the mutated gene. On the contrary, the frequency of ERM and VMT in patients with RPGR- RP was similar to that observed in our overall RP cohort (ERM = 25% in RPGR -RP vs. 19.8% in RP; VMT = 2.5% in RPGR -RP vs. 5% in RP).…”
Section: Discussionmentioning
confidence: 55%
See 2 more Smart Citations
“… 58 This finding is consistent with two previous studies that reported no case of CME in patients with RPGR -RP. 9 , 35 Moreover, the lower frequency of CME observed in patients with X-linked RP (7.1%) compared to autosomal forms reported in our previous study 58 strongly suggest that the incidence of CME in RP varies according to the mutated gene. On the contrary, the frequency of ERM and VMT in patients with RPGR- RP was similar to that observed in our overall RP cohort (ERM = 25% in RPGR -RP vs. 19.8% in RP; VMT = 2.5% in RPGR -RP vs. 5% in RP).…”
Section: Discussionmentioning
confidence: 55%
“… 32 The disease severity associated with ORF15 variants could be attributed to the presumed gain-of-function or dominant-negative effect of the resulting protein product, as previously suggested. 28 , 30 , 35 , 40 Variants in ORF15 are mostly small deletions or duplications leading to frameshift changes. Because ORF15 is the terminal exon of the RPGR ORF15 transcript, the stop or frame-shifting variants are, in principle, not subject to nonsense-mediated mRNA decay, but can be expected to lead to the synthesis of presumably dysfunctional protein products.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is not known why the RPGR mutations result in two contrasting disorders. It seems that the phenotype depends on the location of the mutation: Mutations in the exons 1–14 and the proximal part of the ORF15 exon usually result in retinitis pigmentosa, while the mutations in the distal end of the ORF15 exon cause cone/cone-rod dystrophy [ 11 , 29 , 42 , 43 , 44 ]. There is however a watershed zone of approximately 100 aminoacids between the two regions, where mutations can result in either phenotype, even within the same family [ 29 ], the reasons for which are not understood.…”
Section: Introductionmentioning
confidence: 99%
“…There are 6 previously reported disease-causing genes: rhodopsin (AD: RHO : Online Mendelian Inheritance in Man [OMIM] entry 180380; n = 70 cases), 4 , 6 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 usherin (AR: USH1C : OMIM 605242; n = 2) 2 ; cadherin 23 (AR: CDH23 , OMIM 605516; n = 1) 18 ; retinol dehydrogenase 5 (AR: RDH5 , OMIM 601617; n = 1) 19 ; arrestin (AR: SAG , OMIM 181031; n = 1) 20 ; and more recently, RP GTPase regulator gene (XL, RPGR , OMIM 312610; n = 2). 4 , 21 All previously reported sector RP-causing variants are summarized in Supplemental Table 1 . Currently there are ongoing efforts to develop and approve novel therapeutic options for diseases caused by RPGR -RP and RHO -RP.…”
mentioning
confidence: 99%